Trial Profile
Phase III trial of naloxone nasal spray in the treatment of eating disorders.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2011
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Eating disorders
- Focus Therapeutic Use
- 26 Aug 2011 New trial record